Clinical Guest Contributors

  1. What Happens If The National Cancer Institute Loses Funding? 4/3/2025

    The National Cancer Institute is operating under a continuing resolution that maintains funding at the FY 2024 level of $7.22 billion. But when adjusted for inflation, it effectively reduces the real value of research dollars. So what are the consequences?

  2. Struggling With GxP Systems? There's A DAP For That 4/2/2025

    A typical life sciences enterprise now has 500+ software applications. A digital adoption platform (DAP) is an overlay to help with user adoption, like an advanced version of the MS Word "paperclip" assistant.

  3. 3 Generative AI Prompts To Strengthen Your SOPs Without Sacrificing Compliance 4/1/2025

    Discover three easy and customizable prompts to help support SOP development, refinement, and training — all areas where AI can add immediate value with minimal downside. 

  4. Multiple Partnerships Help Drive Precision Medicine Trial For Parkinson's 3/31/2025

    Neuron23 CMO Sam Jackson, MD, explains the company’s desire to set a new standard in precision medicine for neurology, backed by well-aligned partnerships and fit-for-purpose digital biomarker solutions. 

  5. Gilead Prioritizes Women With Its First HIV Cure Trial In Africa 3/28/2025

    Gilead’s Head Of HIV Cure Program Strategy Devi SenGupta discusses the challenges and triumphs of a groundbreaking HIV cure trial in South Africa.

  6. Navigating The 2025 Medtech Regulatory Landscape In Switzerland And The U.K. 3/26/2025

    Switzerland is working toward reestablishing its relationship with the EU while exploring new avenues. Meanwhile, the U.K. is still rebuilding its regulatory framework post-Brexit.

  7. As FDA's "Sex Differences" Guidance Reemerges, UCB Reaffirms Importance Of Including Women In Clinical Research 3/26/2025

    UCB Biopharma's Marie Teil explores reasons to prioritize women's inclusion in research and how FDA guidance is poised to support that endeavor.

  8. If Patients Want A Better Quality Of Life, Why Isn't That A Focus For Pharma? 3/25/2025

    Medical oncologist Frédéric Fiteni, Ph.D. reveals the widespread industry reluctance to study patient quality of life, describes its importance to patient satisfaction, and offers best practices for its integration.

  9. Gilead Sees Success With HIV PrEP Trial In South Africa 3/24/2025

    Gilead Sciences' Moupali Das, MD, MPH shares how her team completed the Phase 3 trial for HIV PrEP in South Africa amid challenging conditions.

  10. More Than Just A Monitor: Are You Underutilizing Your CRA? 3/20/2025

    Clinical Research Referral Club CEO Elizabeth Tabor explains how — if better utilized — CRAs can help improve trial operations, strengthen site-sponsor relationships, and increase the likelihood of a site securing more studies.